Profile Picture
Rewards
  • All
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Win Nobel Prize in medicine
Biles lands historic vault
To attend civil fraud trial
$2 million bidding war
Prison guard killed by inmate
'Renaissance’ trailer
Gets emotional sendoff
'Just a flesh wound'
100+ dolphins found dead
Plows car into police station
RU painting decoy bombers
'Find it personally disturbing'
Pespas goes missing
7 injured in multi-car crash
Firefighter charged w/ arson
Reflects on the highs and lows
Fire at Egypt police facility
Sustainable mining
Lula leaves hospital
Phoenix driest monsoon
Celtics acquire Jrue Holiday
Invests $200M in Masan
Astros clinch AL West
Stevie Nicks Barbie doll
Reach deal to avoid strike
Ejected for late hit
Top dog at box office
Fastest to reach 200 TDs
Can earn up to $15 million
Couple killed by grizzly bear
Houston shooting kills 2
Mexico church roof collapse
Returns to NFL action
Attends another Chiefs game
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
251,000 results
CBS News18d
First-ever RSV vaccine becomes available
NORTH TEXAS (CBSNewsTexas.com) – For the first time ever, an RSV vaccine has become available to those at high-risk. This comes as cases of the respiratory illness are rising in Texas and across ...
EURACTIV
10d
EU countries should prepare for seasonal respiratory diseases – health agencies
The European Medicines Agency (EMA) and the European Centre for Disease Control (ECDC) recommend targeting people at risk in ...
EuropaWire5d
GSK’s Arexvy RSV Vaccine Approved in Japan for Adults Aged 60 and Above, a First for the Country
GSK plc has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its Arexvy (respiratory ...
New Scientist
12d
What you need to know about the 2023 covid-19 boosters
New Scientist explains how the latest covid-19 booster vaccines are different from previous ones, and who should get them ...
Buffalo News18d
FDA approves RSV vaccine for moms-to-be to guard their newborns
WASHINGTON (AP) — U.S. regulators on Monday approved the first RSV vaccine for pregnant women so their babies will be born with protection against the scary respiratory infection. RSV is ...
pharmaphorum
7d
CDC backs maternal use of Pfizer’s RSV vaccine
The way has been largely cleared for the rollout of Pfizer’s respiratory syncytial virus (RSV) vaccine to help protect ...
Pharmaceutical Technology on MSN
6d
GSK receives Japanese approval of RSV vaccine for older patients
GSK has received approval from Japan’s MHLW for RSV vaccine Arexvy to prevent RSV disease in adults aged over 60 years ...
Billings Gazette
2d
What to know as fall vaccinations against COVID, flu and RSV get underway
For the first time, the U.S. has vaccines to fight a trio of viruses that cause fall and winter misery. But health officials ...
7d
GSK's RSV vaccine gets approval in Japan
GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare ...
9d
RSV vaccine recommended during pregnancy as a second option to protect newborns
U.S. health officials are recommending RSV vaccinations for moms-to-be as a second option to protect newborns. The Centers ...
PMLiVE
5d
Pfizer’s Abrysvo RSV vaccine recommended by US CDC for infants
Pfizer’s respiratory syncytial virus (RSV) vaccine, Abrysvo, that can help to protect infants through the active immunisation of pregnant women, has been backed by the US Centers for Disease Control ...
WAMC8d
CDC recommends RSV vaccine in late pregnancy to protect newborns
In a nearly unanimous vote, advisors to the Centers for Disease Control and Prevention have recommended a new vaccine to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices